Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48,150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Manipulating the Alpha Level Cannot Cure Significance Testing.
Trafimow D, Amrhein V, Areshenkoff CN, Barrera-Causil CJ, Beh EJ, Bilgiç YK, Bono R, Bradley MT, Briggs WM, Cepeda-Freyre HA, Chaigneau SE, Ciocca DR, Correa JC, Cousineau D, de Boer MR, Dhar SS, Dolgov I, Gómez-Benito J, Grendar M, Grice JW, Guerrero-Gimenez ME, Gutiérrez A, Huedo-Medina TB, Jaffe K, Janyan A, Karimnezhad A, Korner-Nievergelt F, Kosugi K, Lachmair M, Ledesma RD, Limongi R, Liuzza MT, Lombardo R, Marks MJ, Meinlschmidt G, Nalborczyk L, Nguyen HT, Ospina R, Perezgonzalez JD, Pfister R, Rahona JJ, Rodríguez-Medina DA, Romão X, Ruiz-Fernández S, Suarez I, Tegethoff M, Tejo M, van de Schoot R, Vankov II, Velasco-Forero S, Wang T, Yamada Y, Zoppino FCM, Marmolejo-Ramos F. Trafimow D, et al. Among authors: wang t. Front Psychol. 2018 May 15;9:699. doi: 10.3389/fpsyg.2018.00699. eCollection 2018. Front Psychol. 2018. PMID: 29867666 Free PMC article. Review.
Making the A Priori Procedure Work for Differences Between Means.
Trafimow D, Wang C, Wang T. Trafimow D, et al. Among authors: wang t, wang c. Educ Psychol Meas. 2020 Feb;80(1):186-198. doi: 10.1177/0013164419847509. Epub 2019 May 14. Educ Psychol Meas. 2020. PMID: 31933498 Free PMC article.
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Chen Y, Du CY, Shen S, Zhang W, Shan Y, Lyu A, Wu J, Shang C, Luo X, Wei J, Xiao H, Qiu J, Hua Y, Wang S, Wang T, Dai S, Zhang S, Xie B, Wu Y, Hao C. Chen Y, et al. Among authors: wang t. Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-24-0006. Online ahead of print. Clin Cancer Res. 2024. PMID: 38687583
48,150 results
You have reached the last available page of results. Please see the User Guide for more information.